December 03, 2009
People News: Alexion Pharmaceuticals and KV Pharmaceutical
Alexion Pharmaceuticals appointed William Keller to its board of directors, effective immediately, bringing to eight the number of members. Keller is founder and general manager of Keller Pharma Consultancy, based in China, and serves as a senior consultant to the Shanghai Foreign Investment Development Board, as well as deputy general manager of Zhangjiang Biotech & Pharmaceutical Base Development Co. From 1976 to 2003, he held various positions with Roche Group in Asia and South America.
Specialty firm KV Pharmaceutical named David Van Vliet CEO, with a term through December 31, 2011. Van Vliet has served as interim president and CEO since December 2008.